Cargando…
43.2 MUSCARINIC M1 RECEPTORS: INVOLVEMENT IN THE PATHOPHYSIOLOGY AND TREATMENT OF SCHIZOPHRENIA
BACKGROUND: Evidence from postmortem CNS studies and a neuroimaging study suggest that, compared to controls, there are low levels of muscarinic receptors in a number of CNS regions from subjects with schizophrenia. Current data suggests the muscarinic M1 receptor is lower in the cortex of subjects...
Autores principales: | Dean, Brian, Hopper, Shaun, Scarr, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888578/ http://dx.doi.org/10.1093/schbul/sby014.180 |
Ejemplares similares
-
The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?
por: Jeon, Won Je, et al.
Publicado: (2015) -
Widespread Changes in Positive Allosteric Modulation of the Muscarinic M(1) Receptor in Some Participants With Schizophrenia
por: Hopper, Shaun, et al.
Publicado: (2019) -
Changes in cortical gene expression in the muscarinic M1 receptor knockout mouse: potential relevance to schizophrenia, Alzheimer’s disease and cognition
por: Dean, Brian, et al.
Publicado: (2021) -
PM484. BQCA Allosteric Modulation of [(3)H]NMS Binding to Human Cortex is Reduced in a Subgroup of Schizophrenia and Modulation by Divalent Cations
por: Hopper, Shaun, et al.
Publicado: (2016) -
43. BUILDING ON GENETICS AND PATHOPHYSIOLOGY OF SCHIZOPHRENIA TO GUIDE DISCOVERY OF NEW TREATMENTS
por: Conn, P Jeffrey
Publicado: (2018)